as 12-18-2024 4:00pm EST
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | ANN ARBOR |
| Market Cap: | N/A | IPO Year: | 2017 |
| Target Price: | $14000.00 | AVG Volume (30 days): | 89.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -128.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.01 - $4882.50 | Next Earning Date: | 11-15-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
NDRA Breaking Stock News: Dive into NDRA Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Business Wire
a month ago
Business Wire
a month ago
Business Wire
a month ago
MT Newswires
2 months ago
MT Newswires
2 months ago
MT Newswires
2 months ago
Business Wire
2 months ago
The information presented on this page, "NDRA ENDRA Life Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.